Anti-CD3 scFv-B7.1 fusion protein expressed on the surface of HeLa cells provokes potent T-lymphocyte activation and cytotoxicity

By Yang Zhang-Min   Li En-Min   Lai Bao-Chang   Wang Yi-Li   Si Lu-Sheng  

Biochemistry and Cell Biology, Vol. 85, Iss. 2, 2007-04 ,pp. : 196-202

NRC Research Press

Access to resources Recommend Favorite

Rationale for anti-CD200 immunotherapy in B-CLL and other hematologic malignancies: new concepts in blocking immune suppression

By Kretz-Rommel Anke   Bowdish Katherine S  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 1, 2008-01 ,pp. : 5-15

Informa Healthcare

Access to resources Recommend Favorite

Requirement of Cell-Cell Contact in the Induction of Jurkat T Cell Apoptosis: The Membrane-Anchored but Not Soluble Form of FasL Can Trigger Anti-CD3-Induced Apoptosis in Jurkat T Cells

By Oyaizu N.   Kayagaki N.   Yagita H.   Pahwa S.   Ikawa Y.  

Biochemical and Biophysical Research Communications, Vol. 238, Iss. 2, 1997-09 ,pp. : 670-675

Elsevier

Access to resources Recommend Favorite

The Adhesion of Anti-CD3-Activated Mouse T Cells to Syngeneic Colon Adenocarcinoma Cells Is Differentially Regulated by Protein Tyrosine Kinase-, Protein Kinase C-, and cAMP-Dependent Pathways in the Effector Cell

By MacKenzie W.M.   Hoskin D.W.   Blay J.  

Biochemical and Biophysical Research Communications, Vol. 255, Iss. 2, 1999-02 ,pp. : 460-465

Elsevier

Access to resources Recommend Favorite

Gemtuzumab ozogamicin: an anti-CD33 immunoconjugate for the treatment of acute myeloid leukaemia

By Stasi Roberto  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 4, 2008-04 ,pp. : 527-540

Informa Healthcare

Access to resources Recommend Favorite